Remedent, Inc. - Amended Current report filing (8-K/A)
July 02 2008 - 11:15AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 10, 2008
REMEDENT, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
|
|
Nevada
|
|
001-15975
|
|
86-0837251
|
|
|
|
|
|
|
(State or Other Jurisdiction of
Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Xavier de Cocklaan 42, 9831, Deurle, Belgium
|
|
|
|
N/A
|
|
|
|
|
|
|
|
(Address of Principal Executive Offices)
|
|
|
|
(Zip Code)
|
011-329-321-7080
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
|
o
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
o
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
TABLE OF CONTENTS
This
filing amends the Current Report on Form
8-K
filed on April 15,
2008 to include a revised redacted version of the Distribution
Agreement with GlamTech USA, Inc. which is filed as an exhibit
hereto. For convenience, all of the exhibits to this Current Report
are being refiled with this amendment.
SECTION 1 — REGISTRANT’S BUSINESS AND OPERATIONS
Item 1.01 Entry into a Material Definitive Agreement.
On April 10, 2008, Remedent N.V., a Belgian company
and a subsidiary of Remedent, Inc. (“Company”),
entered into a distribution agreement (“Agreement”) with
GlamTech USA, Inc., a corporation under
the laws of Delaware (“GlamTech”) whereby GlamTech agreed to be the exclusive distributor of the
Company’s GlamSmile products in the United States of America and Canada.
The term
of the Agreement is for five years and began on April 10, 2008.
The
Agreement is filed as Exhibit 10.1 to this Form 8-K. The
Securities and Exchange Commission granted the Company’s
application to seek confidential treatment of certain portions of the Agreement, such terms have been redacted
from Exhibit 10.1 and have been replaced by the symbol “[ *** ].”
For further information see the Agreement attached hereto as Exhibit 10.1.
SECTION 5—CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective April 30, 2008, Roger Leddington is resigning his position as Senior Vice President and
Head of US Marketing for Remedent. Mr. Leddington guided GlamSmile’s entry into the US market late
last year, and in conjunction with the GlamTech USA, Inc. Distribution Agreement, Mr. Leddington
accepted the position as GlamTech’s President.
SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01. Financial Statements and Exhibits.
|
|
|
|
|
|
|
Exhibit No.
|
|
Exhibit Description
|
|
|
|
|
|
|
|
|
10.1
|
|
|
Distribution Agreement, dated April 10, 2008, by and between
Remedent n.v and GlamTech USA, Inc. *
|
|
|
|
|
|
|
|
|
99.1
|
|
|
Press
Release dated April 15, 2008, “Remedent, Inc. Announces
launch of Exclusive Strategic Marketing Program with GlamTech USA,
Inc. for the Distribution of Glamsmile™ in the United States and
Canada”
|
|
|
|
|
|
|
|
|
|
|
|
*
|
|
The Securities and Exchange Commission granted the
Company’s application to seek confidential
treatment of certain portions of Exhibit 10.1 under Rule 24b-2 of the Securities Exchange Act
of 1934, as amended. Omitted material for which confidential
treatment was granted has been
filed separately with the Securities and Exchange Commission.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
REMEDENT, INC.
,
a Nevada corporation
|
|
|
Dated: July 2, 2008
|
By:
|
/s/ Robin List
|
|
|
|
|
Robin List,
|
|
|
|
|
Chief Executive Officer
|
|
EXHIBIT INDEX
|
|
|
|
|
|
|
Exhibit No.
|
|
Exhibit Description
|
|
|
|
|
|
|
|
|
10.1
|
|
|
Distribution Agreement, dated April 10, 2008, by and between
Remedent n.v and GlamTech USA, Inc. *
|
|
|
|
|
|
|
|
|
99.1
|
|
|
Press
Release dated April 15, 2008, “Remedent, Inc. Announces
launch of Exclusive Strategic Marketing Program with GlamTech USA,
Inc. for the Distribution of Glamsmile™ in the United States and
Canada”
|
|
|
|
|
|
*
|
|
The Securities and Exchange Commission granted the
Company’s application to seek confidential
treatment of certain portions of Exhibit 10.1 under Rule 24b-2 of the Securities Exchange Act
of 1934, as amended. Omitted material for which confidential
treatment was granted has been
filed separately with the Securities and Exchange Commission.
|
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2023 to Jul 2024
